An insurance benefit that provides percutaneous coronary intervention patients with a discharge supply of antiplatelet medication could result in cost savings for insurers. To propose a model in which ...

Treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots. A new study has ...

The results of a clinical trial have shown that a drug commonly used for patients with bleeding disorders has the potential to be used to lessen the side effects of blood-thinning drugs for patients ...

Using proton pump inhibitors (PPIs) and antiplatelet drugs (thienopyridines) together is an appropriate way of treating patients with cardiovascular (CV) disease who are at high risk of upper ...

Physicians now have 11 US Food and Drug Administration-approved antiplatelet drugs available for clinical use. Each has been thoroughly evaluated utilizing stringent criteria for efficacy and safety ...

Current treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots. A new Loyola ...

Adding cilostazol - an antiplatelet medication used to treat leg pain - tended to prevent re-blockage of carotid artery stents within two years, according to late breaking science presented today at ...

DUBLIN--(BUSINESS WIRE)--The "Antiplatelet Market: Analysis By Drug Class, By Route of Administration, By Distribution Channel, By Region Size and Trends" report has been added to ...

You have full access to this article via your institution. Antiplatelet drug use is associated with an increased risk of upper gastrointestinal bleeding (UGIB); data on the impact of gastroprotective ...

When someone survives a heart attack, their recovery journey often includes a small pharmacy of medications—each serving a specific purpose in their healing process and long-term protection.

MAYWOOD, IL - Current treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots ...